Literature DB >> 29848021

Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.

Josie Libertucci1,2, Usha Dutta3, Sandeep Kaur2,4, Jennifer Jury2,4, Laura Rossi1,2, Michelle E Fontes2,4, M Sharif Shajib2,5, Waliul I Khan2,5, Michael G Surette1,2,4, Elena F Verdu2,4, David Armstrong2,4.   

Abstract

Crohn's disease (CD), characterized by discontinuous intestinal injury and inflammation, has been associated with changes in luminal microbial composition and impaired barrier function. The relationships between visual features of intestinal injury, permeability, and the mucosa-associated microbiota are unclear. Individuals undergoing routine colonoscopy (controls) and patients with CD were evaluated by clinical parameters and confocal laser scanning endomicroscopic colonoscopy (CLE). Patients with CD were categorized as either CD with no injury (CD-NI) or CD with injury (CD-I). Colonic biopsies were taken from adjacent matched sites in all individuals, and CLE images from these sites were analyzed for vascular permeability. Microbial composition was evaluated by 16S rRNA gene sequencing of the V3 region, and the mycome was identified through internal transcribed spacer 2 sequencing. Subgroup analyses were performed for histology, paracellular permeability (Ussing chamber), and encroachment of bacteria (fluorescent in situ hybridization). CD-I patients showed an altered microbial community compared with both controls and CD-NI patients, with enrichment in Escherichia and a decrease in Firmicutes, including Lachnospira, Faecalibacterium, and Blautia. In CD-I patients, bacterial encroachment to host epithelial cells was greater in sites of injury than in matched biopsy sites. Biopsies from sites of injury also demonstrated greater vascular and paracellular permeability. Overall, CD-I patients showed an altered mucosal microbial community compared with CD-NI patients and controls. Matched biopsy samples in CD-I patients revealed that sites of injury, identified endoscopically, are characterized by increased encroachment of bacteria to host epithelial cells, associated with increased paracellular and vascular permeability, which may drive inflammation in CD. NEW & NOTEWORTHY Patients with Crohn's disease (CD) with areas of colonic injury have an altered microbial community compared with patients who have no endoscopic evidence of injury or active disease. Although matched biopsies from patients with colonic injury show no differences in the mucosa-associated microbiota, injured sites are associated with increased permeability and increased encroachment. Our results support the notion that dysbiotic communities within patients with colonic injury cause or permit disruption of the mucosal and endothelial layers in CD.

Entities:  

Keywords:  crohn's disease; dysbiosis; microbiota; permeability

Mesh:

Substances:

Year:  2018        PMID: 29848021     DOI: 10.1152/ajpgi.00411.2017

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  9 in total

Review 1.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

Review 2.  Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.

Authors:  Laila Aldars-García; María Chaparro; Javier P Gisbert
Journal:  Microorganisms       Date:  2021-04-30

3.  Effect of the Chinese Medicine YangZheng XiaoJi on Reducing Fatigue in Mice with Orthotopic Transplantation of Colon Cancer.

Authors:  Yanni Zhang; Zhongxin Li; Zhaolong Zhao; Wentao Kuai; Cong Wei; Jian Lv; Jie Zhi; Yitao Jia
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-12       Impact factor: 2.629

4.  Analysis of Oxidative Stress-Related Markers in Crohn's Disease Patients at Surgery and Correlations with Clinical Findings.

Authors:  Cristina Luceri; Elisabetta Bigagli; Sara Agostiniani; Francesco Giudici; Daniela Zambonin; Stefano Scaringi; Ferdinando Ficari; Maura Lodovici; Cecilia Malentacchi
Journal:  Antioxidants (Basel)       Date:  2019-09-06

5.  Dietary protocatechuic acid ameliorates inflammation and up-regulates intestinal tight junction proteins by modulating gut microbiota in LPS-challenged piglets.

Authors:  Ruizhi Hu; Ziyu He; Ming Liu; Jijun Tan; Hongfu Zhang; De-Xing Hou; Jianhua He; Shusong Wu
Journal:  J Anim Sci Biotechnol       Date:  2020-09-09

6.  Association of Adherent-invasive Escherichia coli with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn's disease.

Authors:  Xu Zhilu; Dong Xiangqian; Yang Keli; Chevarin Caroline; Zhang Jingwan; Lin Yu; Zuo Tao; Chu Lok Cheung; Sun Yang; Zhang Fengrui; Chan Francis Kl; Sung Joseph Jy; Yu Jun; Buisson Anthony; Barnich Nicolas; Colombel Jean-Frédéric; Wong Sunny Hei; Miao Yinglei; Ng Siew C
Journal:  Gut Microbes       Date:  2021 Jan-Dec

7.  Bacterial Characteristics of Intestinal Tissues From Patients With Crohn's Disease.

Authors:  Desen Sun; Xiaolong Ge; Shasha Tang; Yaxin Liu; Jun Sun; Yuping Zhou; Liang Luo; Zhengping Xu; Wei Zhou; Jinghao Sheng
Journal:  Front Cell Infect Microbiol       Date:  2021-11-16       Impact factor: 5.293

8.  Reply to "Too Soon to Dismiss Inflammation-Related Differences in the Mucosa-Associated Microbiota in Crohn's Disease Patients".

Authors:  Maya Olaisen; Reidar Fossmark
Journal:  Inflamm Bowel Dis       Date:  2022-08-01       Impact factor: 7.290

9.  Constitution of mucosa-associated microbiota in the lower digestive tract does not change in early stage of non-alcoholic fatty liver disease with fecal dysbiosis.

Authors:  Naoki Asaji; Jun Inoue; Hiroki Hayashi; Eri Tokunaga; Yusaku Shimamoto; Masato Kinoshita; Takeshi Tanaka; Arata Sakai; Yoshihiko Yano; Yoshihide Ueda; Yuzo Kodama
Journal:  JGH Open       Date:  2022-08-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.